Microbiological characteristics and outcomes of children with pleural empyema admitted to a tertiary hospital in southeast China, 2009-2018
Background. Pleural empyema is one of the most serious and life-threatening types of infection in children. The aim of this study was to describe the microbiological characteristics and outcomes of children with pleural empyema. Methods. A retrospective review was conducted of the medical records of 63 children admitted to a tertiary hospital in China with pleural empyema between January 2009 and December 2018. Results. The children had a median age of 1 year (range: 2 months to 16 years) and 33 (52.4%) were female. Bacterial isolates included Staphylococcus aureus (n=15, 23.8%), Streptococcus pneumoniae (n=10, 15.9%), Pseudomonas aeruginosa (n=7, 11.1%), Escherichia coli (n=2, 3.2%), Burkholderia cepacia (n=2, 3.2%), Enterobacter cloacae (n=1, 1.6%), Klebsiella pneumoniae (n=1, 1.6%), and Streptococcus constellation (n=1, 1.6%). All 15 Staphylococcus aureus isolates were found to be resistant to penicillin, and the rate of methicillin-resistant Staphylococcus aureus was high (66.7%,10/15). Overall, 5 of 10 Streptococcus pneumoniae isolates were susceptible to penicillin. Each Staphylococcus aureus and Streptococcus pneumoniae isolate showed susceptibility to vancomycin. Ceftazidime was effective against all Pseudomonas aeruginosa isolates. Of the 63 children, 60 improved, no one died. Conclusions. Staphylococcus aureus and Streptococcus pneumoniae were the leading cause of pleural empyema. Antimicrobial susceptibility testing revealed a high percentage of resistance against penicillin while vancomycin provided 100% coverage for these pathogens. Pseudomonas aeruginosa is the third most common pathogen mainly detected in those under 3 years old in the summer and have shown to be susceptible to ceftazidime. The prognosis is good after appropriate therapy
___
1. Mandal KC, Mandal G, Halder P, Mitra D, Debnath B, Bhattacharya M. Empyema thoracis in children: a 5-year experience in a tertiary care institute. J Indian Assoc Pediatr Surg 2019; 24: 197-202. https://doi. org/10.4103/jiaps.JIAPS_112_182. Corcoran JP, Wrightson JM, Belcher E, DeCamp MM, Feller-Kopman D, Rahman NM. Pleural infection: past, present, and future directions. Lancet Respir Med 2015; 3: 563-577. https://doi.org/10.1016/S2213- 2600(15)00185-X
3. Dyrhovden R, Nygaard RM, Patel R, Ulvestad E, Kommedal Ø. The bacterial aetiology of pleural empyema. A descriptive and comparative metagenomic study. Clin Microbiol Infect 2019; 25: 981-986. https://doi.org/10.1016/j.cmi.2018.11.030
4. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 2011; 66: 663-668. https://doi.org/10.1136/ thx.2010.156406
5. Liese JG, Schoen C, van der Linden M, et al. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study. Clin Microbiol Infect 2019; 25: 857-864. https:// doi.org/10.1016/j.cmi.2018.10.020
6. Bedawi EO, Hassan M, McCracken D, Rahman NM. Pleural infection: a closer look at the etiopathogenesis, microbiology and role of antibiotics. Expert Rev Respir Med 2019; 13: 337-347. https://doi.org/10.1080 /17476348.2019.1578212
7. Balfour-Lynn IM, Abrahamson E, Cohen G, et al; Paediatric Pleural Diseases Subcommittee of the BTS Standards of Care Committee. BTS guidelines for the management of pleural infection in children. Thorax 2005; 60(Suppl 1): i1-i21. https://doi.org/10.1136/ thx.2004.030676
8. Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg 2017; 153: e129-e146. https://doi.org/10.1016/j.jtcvs.2017.01.030
9. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002; 34: 434-440. https://doi.org/10.1086/338460
10. Lamas-Pinheiro R, Henriques-Coelho T, Fernandes S, et al. Thoracoscopy in the management of pediatric empyemas. Rev Port Pneumol (2006) 2016; 22:157- 162. https://doi.org/10.1016/j.rppnen.2015.12.004
11. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north-east of England. Thorax 2004; 59: 522-555. https://doi.org/10.1136/thx.2003.016105
12. Mahon C, Walker W, Drage A, Best E. Incidence, aetiology and outcome of pleural empyema and parapneumonic effusion from 1998 to 2012 in a population of New Zealand children. J Paediatr Child Health 2016; 52: 662-668. https://doi. org/10.1111/jpc.13172
13. Kumar A, Sethi GR, Mantan M, Aggarwal SK, Garg A. Empyema thoracis in children: a short-term outcome study. Indian Pediatr 2013; 50: 879-882. https://doi.org/10.1007/s13312-013-0232-8
14. Baranwal AK, Singh M, Marwaha RK, Kumar L. Empyema thoracis: a 10-year comparative review of hospitalised children from south Asia. Arch Dis Child 2003; 88: 1009-1014. https://doi.org/10.1136/ adc.88.11.1009
15. Chacon-Cruz E, Rivas-Landeros RM, Volker- Soberanes ML, Lopatynsky-Reyes EZ, Becka C, Alvelais-Palacios JA. 12 years active surveillance for pediatric pleural empyema in a Mexican hospital: effectiveness of pneumococcal 13-valent conjugate vaccine, and early emergence of methicillin- resistant Staphylococcus aureus. Ther Adv Infect Dis 2019; 6: 2049936119839312. https://doi. org/10.1177/2049936119839312
16. Meyer Sauteur PM, Burkhard A, Moehrlen U, et al. Pleural tap-guided antimicrobial treatment for pneumonia with parapneumonic effusion or pleural empyema in children: a single-center cohort study. J Clin Med 2019; 8: 698. https://doi.org/10.3390/ jcm8050698
17. Haggie S, Gunasekera H, Pandit C, Selvadurai H, Robinson P, Fitzgerald DA. Paediatric empyema: worsening disease severity and challenges identifying patients at increased risk of repeat intervention. Arch Dis Child 2020; 105: 886-890. https://doi.org/10.1136/archdischild-2019-318219
18. de Benedictis FM, Carloni I, Osimani P, et al. Prospective evaluation of lung function in children with parapneumonic empyema. Pediatr Pulmonol 2019; 54: 421-427. https://doi.org/10.1002/ppul.24204
19. Krenke K, Sadowy E, Podsiadły E, Hryniewicz W, Demkow U, Kulus M. Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests. Respir Med 2016; 116: 28-33. https://doi.org/10.1016/j. rmed.2016.05.009
20. Lin TY, Hwang KP, Liu CC, et al. Etiology of empyema thoracis and parapneumonic pleural effusion in Taiwanese children and adolescents younger than 18 years of age. Pediatr Infect Dis J 2013; 32: 419-421. https://doi.org/10.1097/INF.0b013e31828637b1
21. Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 2011; 30: 289-294. https://doi.org/10.1097/INF.0b013e3182002d14
22. Amin M, Yousef Pour S, Navidifar T. Detection of the major bacterial pathogens among children suffering from empyema in Ahvaz city, Iran. J Clin Lab Anal 2019; 33: e22855. https://doi.org/10.1002/jcla.22855
23. Fujitani S, Sun HY, Yu VL, Weingarten JA. Pneumonia due to pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest 2011; 139: 909-919. https://doi.org/10.1378/ chest.10-0166
24. Gayretli-Aydın ZG, Tanır G, Bayhan Gİ, et al. Evaluation of complicated and uncomplicated parapneumonic effusion in children. Turk J Pediatr 2016; 58: 623-631. https://doi.org/10.24953/ turkjped.2016.06.008
25. Livingston MH, Mahant S, Connolly B, et al. Effectiveness of intrapleural tissue plasminogen activator and dornase alfa vs tissue plasminogen activator alone in children with pleural empyema: a randomized clinical trial. JAMA Pediatr 2020; 174: 332-340. https://doi.org/10.1001/ jamapediatrics.2019.5863
26. Maffey A, Colom A, Venialgo C, et al. Clinical, functional, and radiological outcome in children with pleural empyema. Pediatr Pulmonol 2019; 54: 525-530. https://doi.org/10.1002/ppul.24255
- ISSN: 0041-4301
- Yayın Aralığı: Yılda 6 Sayı
- Başlangıç: 1958
- Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler
Yeter Düzenli KAR, Zeynep Canan ÖZDEMİR, Kürşat Bora ÇARMAN, Coşkun YARAR, Neslihan TEKİN, Özcan BÖR
Clinical follow-up of children with high vitamin B12 values: should we worry?
Davut ALBAYRAK, Canan ALBAYRAK
Sevliya ÖCAL DEMİR, Eda KEPENEKLİ, Gülşen AKKOÇ, Nurhayat YAKUT, Ahmet SOYSAL
A case of pediatric psoriasis achieving remission after allogenic bone marrow transplantation
Dilara GÜLER, Gülhan GÜREL, Gülsüm Şeyma YALÇIN, İbrahim EKER, İrem Nur DURUSU, Çiğdem ÖZDEMİR, Özge VURAL
Serdar GÜL, Cemile SÖNMEZ, Gökçe AYVAZ, Selçuk KILIÇ
Elif Soyak AYTEKİN, Deniz ÇAĞDAŞ, Çağman TAN, Büşranur ÇAVDARLI, Işıl BİLGİÇ, İlhan TEZCAN
Canan ÖZLÜ, Serkan TÜRKUÇAR, Hatice KARAOĞLU ASRAK, Hatice Adıgüzel DÜNDAR, Şevket Erbil ÜNSAL, Nurşen BELET
The relationship between immature platelet fraction and severity of acute bronchiolitis
Murat DOĞAN, Mehmet KÖSE, Mehmet Adnan ÖZTÜRK, Melih HANGÜL, Hümeyra ASLANER
Sare Gülfem ÖZLÜ, Bora GÜLHAN, Özlem AYDOĞ, Emine ATAYAR, Ali DELİBAŞ, Gönül PARMAKSIZ, Elif Bahat ÖZDOĞAN, Elif ÇOMAK, Mehmet TAŞDEMİR, Banu ACAR, Zeynep Birsin ÖZÇAKAR, Rezan TOPALOĞLU, Oğuz SÖYLEMEZOĞLU, Fatih ÖZALTIN